List of works by Kiyokazu Atake

Abnormal white matter integrity in the corpus callosum among smokers: tract-based spatial statistics

scientific article

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients

scientific article

Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.

scientific article published on 06 March 2017

Brain-derived neurotrophic factor (BDNF) and mood disorder

scientific article published on November 2010

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder

scientific article published on 3 April 2015

Comparison of lithium, aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder

scientific article

Current smoking rate in patients with psychiatric disorders in Japan: questionnaire survey

scientific article published on 17 April 2013

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

scientific article published on 24 April 2014

Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review

scientific article published on 24 April 2013

No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia.

scientific article

Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls

scientific article published in November 2010

Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder

scientific article published on 30 June 2013

Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling Task

scientific article

Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy

scientific article published on 13 July 2016

Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year

scientific article published on 11 September 2019

Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs.

scientific article published on 21 January 2014

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

scientific article published on 10 August 2012

Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia

scientific article published on 14 January 2016

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.

scientific article

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients

scientific article

The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy

scientific article published in March 2012